share_log

Ingevity Analyst Ratings

Ingevity Analyst Ratings

Ingevity 分析师评级
Benzinga ·  2023/08/07 05:13
Date Upside/Downside Analyst Firm Price Target Change Rating Change Previous / Current Rating
08/07/2023 3.16% BMO Capital $71 → $60 Downgrades Outperform → Market Perform
07/27/2023 Loop Capital Upgrades Hold → Buy
05/23/2023 -5.43% Wells Fargo $66 → $55 Maintains Equal-Weight
05/09/2023 37.55% BMO Capital $100 → $80 Maintains Outperform
05/05/2023 13.48% Wells Fargo $80 → $66 Maintains Equal-Weight
05/05/2023 10.04% Loop Capital $92 → $64 Downgrades Buy → Hold
04/17/2023 37.55% Wells Fargo $85 → $80 Maintains Equal-Weight
03/24/2023 58.18% Loop Capital $100 → $92 Maintains Buy
03/01/2023 46.15% Wells Fargo $76 → $85 Maintains Equal-Weight
02/02/2023 71.94% Loop Capital $81 → $100 Upgrades Hold → Buy
01/09/2023 30.67% Wells Fargo $73 → $76 Maintains Equal-Weight
11/04/2022 25.52% Wells Fargo $67 → $73 Maintains Equal-Weight
10/18/2022 15.2% Wells Fargo $74 → $67 Maintains Equal-Weight
10/11/2022 49.59% BMO Capital $89 → $87 Maintains Outperform
05/09/2022 27.24% Wells Fargo $70 → $74 Maintains Equal-Weight
10/29/2021 44.43% Wells Fargo $82 → $84 Maintains Equal-Weight
07/29/2021 63.34% Oppenheimer $85 → $95 Maintains Outperform
05/04/2021 89.13% BMO Capital $100 → $110 Maintains Outperform
08/06/2020 44.43% BMO Capital $79 → $84 Maintains Outperform
07/31/2020 13.48% Stifel $55 → $66 Upgrades Hold → Buy
05/01/2020 -5.43% Wells Fargo $43 → $55 Maintains Equal-Weight
04/30/2020 11.76% Oppenheimer $80 → $65 Maintains Outperform
04/03/2020 -26.07% Wells Fargo → $43 Downgrades Overweight → Equal-Weight
03/24/2020 -27.79% Stifel $67 → $42 Maintains Hold
02/21/2020 15.2% Stifel $76 → $67 Maintains Hold
01/24/2020 Loop Capital Upgrades Hold → Buy
12/06/2019 65.06% Loop Capital → $96 Downgrades Buy → Hold
10/16/2019 71.94% Wells Fargo → $100 Initiates Coverage On → Outperform
09/27/2019 118.36% BMO Capital $131 → $127 Maintains Outperform
09/25/2019 70.22% Stifel $109 → $99 Maintains Hold
09/05/2019 Loop Capital Upgrades Hold → Buy
07/19/2019 83.98% Jefferies $129 → $107 Downgrades Buy → Hold
07/18/2019 BMO Capital Initiates Coverage On → Outperform
05/28/2019 Berenberg Upgrades Hold → Buy
05/28/2019 89.13% Berenberg $120 → $110 Upgrades Hold → Buy
04/08/2019 123.52% Oppenheimer $110 → $130 Maintains Outperform
12/11/2018 44.43% Stifel → $84 Initiates Coverage On → Hold
日期 上行/下行 分析公司 目标价格变化 评级变化 上一次/当前评级
08/07/2023 3.16% 蒙特利尔银行资本 $71→$60 评级下调 跑赢→市场表现
07/27/2023 - 环路资本 升级 持有→购买
2023年05月23日 -5.43% 富国银行 $66→$55 维护 等重
05/09/2023 37.55% 蒙特利尔银行资本 $100→$80 维护 跑赢大盘
05/05/2023 13.48% 富国银行 $80→$66 维护 等重
05/05/2023 10.04% 环路资本 $92→$64 评级下调 购买→Hold
04/17/2023 37.55% 富国银行 $85→$80 维护 等重
03/24/2023 58.18% 环路资本 $100→$92 维护
03/01/2023 46.15% 富国银行 $76→$85 维护 等重
02/02/2023 71.94% 环路资本 $81→$100 升级 持有→购买
01/09/2023 30.67% 富国银行 $73→$76 维护 等重
11/04/2022 25.52% 富国银行 $67→$73 维护 等重
10/18/2022 15.2% 富国银行 $74→$67 维护 等重
2022年10月11日 49.59% 蒙特利尔银行资本 $89→$87 维护 跑赢大盘
05/09/2022 27.24% 富国银行 $70→$74 维护 等重
10/29/2021 44.43% 富国银行 $82→$84 维护 等重
07/29/2021 63.34% 奥本海默 $85→$95 维护 跑赢大盘
05/04/2021 89.13% 蒙特利尔银行资本 $100→$110 维护 跑赢大盘
08/06/2020 44.43% 蒙特利尔银行资本 $79→$84 维护 跑赢大盘
07/31/2020 13.48% Stifel $55→$66 升级 持有→购买
05/01/2020 -5.43% 富国银行 $43→$55 维护 等重
04/30/2020 11.76% 奥本海默 $80→$65 维护 跑赢大盘
04/03/2020 -26.07% 富国银行 →$43 评级下调 超重→等重
03/24/2020 -27.79% Stifel $67→$42 维护 保持
02/21/2020 15.2% Stifel $76→$67 维护 保持
1/24/2020 - 环路资本 升级 持有→购买
2019年6月12日 65.06% 环路资本 →$96 评级下调 购买→Hold
2019年10月16日 71.94% 富国银行 →$100 开始承保 →跑赢大盘
2019年09月27日 118.36% 蒙特利尔银行资本 $131→$127 维护 跑赢大盘
2019年09月25日 70.22% Stifel $109→$99 维护 保持
2019年05月09日 - 环路资本 升级 持有→购买
2019年07月19日 83.98% 杰富瑞 $129→$107 评级下调 购买→Hold
2019年07月18日 - 蒙特利尔银行资本 开始承保 →跑赢大盘
2019年05月28日 - 贝伦伯格 升级 持有→购买
2019年05月28日 89.13% 贝伦伯格 $120→$110 升级 持有→购买
2019年08月04日 123.52% 奥本海默 $110→$130 维护 跑赢大盘
2018年12月11日 44.43% Stifel →$84 开始承保 →保留

What is the target price for Ingevity (NGVT)?

英杰华(Ingevity)的目标价是多少?

The latest price target for Ingevity (NYSE: NGVT) was reported by BMO Capital on August 7, 2023. The analyst firm set a price target for $60.00 expecting NGVT to rise to within 12 months (a possible 3.16% upside). 14 analyst firms have reported ratings in the last year.

BMO Capital于2023年8月7日报道了Ingevity(纽约证券交易所代码:NGVT)的最新目标价。这家分析公司将目标价定为60.00美元,预计NGVT将在12个月内升至(可能上涨3.16%)。过去一年,有14家分析公司公布了评级。

What is the most recent analyst rating for Ingevity (NGVT)?

Ingevity(NGVT)的最新分析师评级是多少?

The latest analyst rating for Ingevity (NYSE: NGVT) was provided by BMO Capital, and Ingevity downgraded their market perform rating.

BMO Capital提供了对Ingevity(纽约证券交易所代码:NGVT)的最新分析师评级,Ingevity下调了他们的市场表现评级。

When is the next analyst rating going to be posted or updated for Ingevity (NGVT)?

Ingevity(NGVT)的下一次分析师评级将于何时发布或更新?

Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Ingevity, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Ingevity was filed on August 7, 2023 so you should expect the next rating to be made available sometime around August 7, 2024.

分析师在进行了广泛的研究后得出了股票评级,其中包括查阅公共财务报表,与Ingevity的高管和客户交谈,以及收听收益电话会议。大多数分析师每三个月就会这样做一次,所以你每年应该会得到每家公司每家公司的4个评级。Ingevity的上一次评级是在2023年8月7日提交的,所以你应该预计下一次评级将在2024年8月7日左右提供。

Is the Analyst Rating Ingevity (NGVT) correct?

分析师评级Ingevity(NGVT)正确吗?

While ratings are subjective and will change, the latest Ingevity (NGVT) rating was a downgraded with a price target of $71.00 to $60.00. The current price Ingevity (NGVT) is trading at is $58.16, which is out of the analyst's predicted range.

虽然评级是主观的,并将发生变化,但最新的Ingevity(NGVT)评级被下调,目标价为71.00美元至60.00美元。英杰华(Ingevity)目前的股价为58.16美元,超出了分析师的预测区间。

声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    抢沙发